Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
LONDON - HSBC Holdings (LON:HSBA) PLC has announced changes in the board memberships of Dr. José Antonio Meade Kuribreña, an independent non-executive Director of the bank. In a recent shift of positions within the corporate landscape, Dr. Meade stepped down from the board of Alfa, S.A.B. de C.V., a conglomerate involved in a variety of industries, on March 25, 2025.
Shortly after his departure from Alfa, Dr. Meade was appointed to the board of Nemak, S.A.B. de C.V., effective March 27, 2025. Nemak, which specializes in the production of aluminum components for the automotive industry, is a former subsidiary of Alfa.
Additionally, Dr. Meade was invited to join the board of Alpek, S.A.B. de C.V. during a shareholder meeting held on April 1, 2025. Alpek, another former subsidiary of Alfa that focuses on the petrochemical sector, will not see Dr. Meade accept the board position offer.
Following these recent developments, Dr. Meade now holds directorships in four listed companies, with HSBC being his primary commitment. The bank’s statement underscores the significance of Dr. Meade’s role within HSBC, where he continues to serve as an independent non-executive Director.
HSBC, headquartered in London, operates internationally with offices in 58 countries and territories. As one of the world’s largest banking and financial services organizations, HSBC reported assets of US$3,017 billion as of December 31, 2024.
The announcement of these board membership changes is in accordance with UK Listing Rule 6.4.9(2) and has been disseminated by RNS, the news service of the London Stock Exchange (LON:LSEG). This statement is based on a press release issued by HSBC Holdings plc (NYSE:HSBC).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.